Suzuken Co. Ltd.

Pharmaceuticals
Japan
Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$16,833
Current Liabilities (US$ Millions)$6,236
Total Assets (US$ Millions)$7,372
Long Term Debt$1
Return on Equity7.88%
Revenue (US$ Millions)$18,515
Total Company Assets$9,789
Revenue Growth (%)13.13%
Net Income (US$ Millions)$241
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$3,270
Profit Margin (%)1.30%
Debt To Equity Ratio (%)0.00%
Inventory Turnover$1,251